Meanwhile, analysis of PCR positive swabs carried out on nearly 7,000 patients in the UK arm of Oxford‘s trial suggests the vaccine may reduce transmission by 67 per cent.
Meanwhile, analysis of PCR positive swabs carried out on nearly 7,000 patients in the UK arm of Oxford‘s trial suggests the vaccine may reduce transmission by 67 per cent.